| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974564 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
The use of an alternate list can expand the applicability of HT to patients who would otherwise be denied this therapy. Although associated with greater morbidity and mortality than standard-list HT, alternate-list HT resulted in clinical outcomes that were significantly better than the natural history of end-stage heart failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
G. Michael MD, Carmelo A. MD, Jonathan E.E. MD, Adrian F. MD, Laura NP, Michael B. MD, Andrew J. MD, Stuart D. MD,